Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND6 pseudogene 21 (MTND6P21) is a nuclear-encoded pseudogene related to the mitochondrial ND6 gene, which normally codes for the ND6 subunit of complex I in the mitochondrial respiratory chain. Unlike the protein-coding ND6 gene—which plays a vital role in mitochondrial energy metabolism and is implicated in diseases such as Leber hereditary optic neuropathy and Leigh syndrome[1][2][5]—MTND6P21 is a non-coding pseudogene, and evidence for its functional biological role or association with human disease is highly limited. Some studies suggest possible expression changes in mitochondrial pseudogenes and isoforms in neurodegenerative diseases, but these links remain unconfirmed and preliminary[4]. There are no known drugs, mechanisms, biomarkers, or safety concerns directly related to MTND6P21. *Note: If a functional target related to the ND6 subunit is required, refer to the canonical mitochondrial ND6 gene (MT-ND6), not MT-ND6 pseudogene 21.*
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND6 pseudogene 21 (MTND6P21).